Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176943 · ClinicalTrials.gov registry record · Phase 4
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
A Phase 4 study, sponsored by Hordinsky, Maria K., MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00176943: Completed Phase 4 study, sponsored by Hordinsky, Maria K., MD.
NCT00176943 is a Phase 4 study that has completed, run by Hordinsky, Maria K., MD. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00176943, a Phase 4 study, has completed, sponsored by Hordinsky, Maria K., MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
It is thought that alopecia areata occurs as the result of an inappropriate response of the body's own immune system to certain substances in or around the hair follicle. We will be examining the efficacy of Aldara Cream 5% in treating extensive alopecia areata and observe its affect on the hair follicle.
Interventions
- DRUG Aldara Cream 5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2000-10 |
| Est. Completion | 2002-08 |
| Phase | Phase 4 |
What the finished NCT00176943 record still lists
NCT00176943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Aldara Cream 5% is the first listed.
NCT00176943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00176943 about?
NCT00176943 is a clinical study titled "Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%". It is thought that alopecia areata occurs as the result of an inappropriate response of the body's own immune system to certain substances in or around the hair follicle. We will be examining the efficacy of Aldara Cream 5% in treating extensive alopecia areata and observe its affect on the hair fol...
What is the current status of trial NCT00176943?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2000-10. Estimated completion is 2002-08.
What interventions are being tested in trial NCT00176943?
The interventions under investigation include: Aldara Cream 5% (DRUG).
Who is sponsoring clinical trial NCT00176943?
This trial is sponsored by Hordinsky, Maria K., MD, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00176943's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia